Stroke & Vascular Disorders
Sneddon syndrome
Apr. 21, 2022
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Schematic representation of the main lipid disorders that affect the skeletal muscle cell. ATP: adenosine triphosphate, CACT: carnitine-acylcarnitine translocase, CPTI: carnitine palmitoyltransferase I, CPT II: carnitine palmitoyltransferase II, ETF: electron transfer flavoprotein, ETFDH: electron transfer flavoprotein dehydrogenase, FADH2: flavin adenine dinucleotide, FFA: free fatty acids, IMM: internal mitochondrial membrane, LCFAT: long-chain fatty acid transporter, MCAD: medium-chain acyl-CoA dehydrogenase, MTP: mitochondrial trifunctional protein, NADH: nicotinamide adenine dinucleotide, OCTN2: organic cation/carnitine transporter 2, OMM: outer mitochondrial membrane, SCAD: short-chain acyl-CoA dehydrogenase, TCA: tricarboxylic acid, VLCAD: very long-chain acyl-CoA dehydrogenase. (Contributed by Dr. Ezequiel Piccione.)